{"slug":"discontinued","tag":"discontinued","variants":["discontinued"],"description":"No description yet","count":1,"kinds":{"target":1},"related":[],"records":[{"id":"liv1","kind":"target","name":"LIV-1 (SLC39A6)","route":"/targets/liv1/","tldr":"LIV-1 is an oestrogen-regulated zinc transporter on most breast cancers; the ADC against it (ladiratuzumab vedotin) showed activity in triple-negative disease but was discontinued in 2024."}]}